EMCORE Corporation (NASDAQ: EMKR)
|
|
- Deborah Carpenter
- 5 years ago
- Views:
Transcription
1 March 27, 2008 Technology Semiconductors Company Update Rating: BUY Price: $5.95 Price Target: $20.00 Bloomberg: NASDAQ: EMKR Market Data 52-Week Range: $15.90-$4.32 Total Entprs. Value (MM): $306.7 Market Cap. (MM): $315.3 Insider Ownership: 35.8% Institutional Ownership: 68.1% Shares Out. (MM): 51.1 Float (MM): 51.1 Avg. Daily Vol.: 698,474 Financial Summary Book Value (MM): $152.2 Book Value/Share: $2.87 Net Debt (MM): ($8.6) Long-Term Debt (MM): $95.9 USD 2006A 2007A 2008E 2009E Rev. (MM) EV/Rev. 1.9x 1.8x 1.1x 0.7x EPS Dec (0.10) (0.13) (0.13) 0.13 Mar (0.07) (0.18) (0.05) 0.15 Jun (0.08) (0.08) Sep (0.18) (0.13) FY Sep (0.44) (0.52) (0.11) 0.64 FY P/E NM NM NM 9.3x Consensus (0.10) 0.41 John Lau, P.E. (212) , EMCORE Corporation (NASDAQ: EMKR) CPV Industry Summit in Spain Signals Accelerating Adoption Investment Summary While EMKR's Solar CPV business continues to gain traction, its Fiber Optic unit is also strong, coupled with its recent acquisition of Intel's FO unit. With improving fundamentals and accelerating Solar orders, we feel EMKR is undervalued in the FO & Clean Tech sectors. Maintain Buy and PT of $20. Event We will attend the first commercial Concentrated Photovoltaic (CPV)Industry Summit held in Madrid, Spain on April 1-2 Key Points First Concentrated Photovoltaic Industry Summit to take place in Madrid on April 1-2: We will attend the CPV summit organized by CPV Today in Madrid on April 1-2. More than 120 executives from the industry will be attending this 2-day event. We believe the Madrid event would be the first such commercial summit exclusively devoted to the CPV industry and is indicative of the industry hitting the knee in the adoption curve. Many companies start to implement CPV Technology - In our report today, we highlight many companies that are developing and installing CPV systems along with how they were funded. These companies will attend the CPV Summit next week to talk about their installations and showcase their products. CPV technology's value proposition is attractive over the long-term: According to CPV Today, the CPV industry aggregate output increased from 1MW in 2004 to 18MW in We believe the technology enjoys installation cost advantage over silicon with per MW cost. EMKR has already achieved photoelectric conversion efficiency of 39% (one of the highest in the world) and further improvements in efficiency will continue to lower costs. Operational improvements will likely make CPV even more cost-effective: Unlike conventional flat panels which use sunlight in its available direct form, CPV technology concentrate sunlight 500x or even higher and uses much less semiconductor content. Research is being done in this area in order to optimize yield and reduce costs. Valuations remain compelling - We would maintain our Buy rating and $20 PT on EMKR. We remain comfortable with the fundamentals for EMKR and their solid business prospects going forward. Refer to our valuation analysis in our report. For the current quarter, we are modeling revenue and EPS estimates of $55.2MM/($0.05). We are maintaining our FY2008 sales estimates at $266.8MM. For FY09, we forecast sales and pro forma EPS of $469MM/$0.64. Valuation/Risks Our $20 price target is based on a sum of the parts methodology and NTM P/S multiple of 2.5x vs. a historical range of 1.1x-4.0x. We are valuing EMKR's solar business at 4x vs. the historical range for the solar sector of 3x-7x. Risks include, but are not limited to, the ability to win terrestrial solar contracts and competition in fiber optics market.
2 Company Description EMCORE manufactures a broad portfolio of compound semiconductor-based components and subsystems such as Fiber Optic Modules, Solar Cells, and RF Wafers. These products are used in Cable Television (CATV), Fiber-to-the-Premise (FTTP), Telecommunications Infrastructure, Data Storage Networks, Satellite, and Wireless Communications markets. John Lau, P.E., jlau@jefferies.com, (212) Page 2 of 10
3 First commercial Concentrated Photovoltaic (CPV) Summit to take place in Madrid, Spain on April 1-2: More than 120 executives from the CPV industry will be attending the 2-day summit. We believe the Madrid event would be the first such summit exclusively devoted to commercialize the CPV industry and is indicative of the industry hitting knee in the adoption curve. Participating companies include Emcore, Green & Gold Energy, AzureSpace, Isofoton and SolFocus among many others. CPV technology's value proposition is attractive over the long-term: CPV technology is still at its infancy but will continue to gain significant traction. According to CPV Today, the CPV industry aggregate output increased from 1MW in 2004 to 18MW in We believe the CPV technology will have cost advantage over silicon based solutions. EMKR has already achieved photoelectric conversion efficiency of 39% and is on track to take to be in the low 40% in the next few years. The progressively improving efficiency levels of GaAs-based CPV solutions should continue to reduce area requirements and lower costs also. Operational improvements will likely make CPV even more cost-effective: Unlike conventional flat panels which use sunlight in its direct available form, CPV technology uses concentrated sunlight by 500x or even higher. Research is being done in this area in order to optimize yield and reduce costs. At the summit, we expect to hear from companies working on these improvements. The following are examples of some of the CPV solution companies presenting at the Madrid summit. We believe such companies are either customers already or potential EMKR customers as GaAs based CPV technology gains traction in the terrestrial applications. ISFOC, Spain: ISFOC or Institute for Concentration Photovoltaic Systems is currently installing 1.7MW CPV plant in Spain, the worlds largest. ISFOC receives funding for the Spanish government. In 2008, another CPV plant with 1.3MW of installed capacity will be built. EMKR is one of the companies that won competitive tender on this project. Solar Systems: Solar Systems is a private company based in Melbourne, Australia that builds and operates solar concentrator photovoltaic power stations. According to the company, they recently completed construction of three concentrator dish power stations in Northern Australia. The $7MM project is currently producing electricity to complement the existing diesel generators under a long term contract with Power and Water Corporation, an electricity supplier. The project consists of 30 dishes and will supply approximately 30%-50% of the community s daytime power requirements. The company noted that this project enabled them to acquire valuable field experience that resulted in a significant reduction in system costs and significant improvements in cell efficiency. Figure 1: Solar Power Plant built by Solar Systems in Australia (NASDAQ:EMKR) Source: Solar Systems The company is also undertaking a similar project in Coober Pedy in South Australia. Solar Systems announced on February 19, 2008 that it would build a $7.1MM power plant with 26 solar dishes. The dishes are to be purchased by EnGen, the owner of the existing Coober Pedy diesel power station. The Australian Government announced that it would provide $3.55MM of funding toward the project under the Renewable Remote Power Generation Program (RRPGP). The South Australian Government also announced that it would provide $635K John Lau, P.E., jlau@jefferies.com, (212) Page 3 of 10
4 toward the project. Electricity generated from these dishes will help offset the use of diesel in the town and will be connected to the Coober Pedy electricity grid. Finally, Solar Systems was granted planning approval to construct a large scale solar demonstration in Bridgewater Australia. This $10MM dollar test facility will start construction this year and according to the company it will be complete in This is the first step toward Solar Systems CPV technology getting utilized for large scale power generation into the Australian national electric grid. This is to be part of a $420MM, 154MW large scale solar concentrator power station in the North-West of Victoria. The Federal and State governments of Australia have announced grants toward the Victoria project to the tune of $125MM. The Federal Government s Low Emission Technology Demonstration Fund (LETDF) will contribute $75MM. Another $50MM in funding will be provided by a grant from the Victorian Government. TRUenergy (China Light & Power Group) has purchased 20% stake in Solar Systems for $40MM and has signed a development agreement for $290MM to finance the balance of the Victoria project. Solar Systems is backed by a group of private investors in addition to TRU energy. The company has received over $50MM in funding so far, according to its website. SolFocus: SolFocus designs and implements solar power solutions using CPV technology. The company has partnered with Xerox s Palo Alto Research Center (PARC) and, according to the company press release, PARC contributes core patents and long term technology for royalties and equity in the privately held company. The company also reported that it was awarded a 500kw contract for the ISFOC project launched in Spain and they were also the first company to install a power producing system in that project during January of The 3MW project in Castilla La Mancha is a worldwide initiative sponsored by Spain s national ministry of Education and funded by the Spanish government. Figure 2: SolFocus CPV installation at ISFOC of Spain Source: SolFocus, Inc In another commercial deal struck in February this year, KGO radio in San Francisco announced that it would use the SolFocus system to power its radio transmissions. The project is estimated to generate 12Kw of power upon completion in 1H2008. Solfocus has successfully raised over $95MM in funding from VC firms since its inception in November Investors include New Enterprise Associates, Moser Baer Photovoltaic, Ltd., David Gelbaum Group, NGEN Partners and Yellowstone Capital Inc. John Lau, P.E., jlau@jefferies.com, (212) Page 4 of 10
5 Sol3G: Founded in Terressa, Spain in 2004, Sol3G is emerging as a significant player in the Solar energy space. They recently added a new plant in Barcelona with production capacity up to 5Mw. By the end or 2008, the company should have production capacity up to 10Mw total. Figure 3: Sol3G Manufacturing Facility in Spain Source: Sol3G Sol3G has many successful installations under its belt with solar projects completed in Denmark, Girona, Lleida, Barcelona, Sevilla, and Madrid. Most recently, the company completed an 8kWp pilot installation for Enel in Sicily. This is the first of the two deliveries that will be necessary to complete the Italian Energy Company s project. Sol3G has also been awarded a 400Kw contract for the ISFOC 3Mw project in Castilla La Mancha Spain. In 2008, Sol3G plans to product and sell 5Mw of concentrated photovoltaic products. Figure 4: Illustration of Sol3G s CPV System Source: Sol3G John Lau, P.E., jlau@jefferies.com, (212) Page 5 of 10
6 Emcore Sum of the Parts Analysis suggests trough valuation at current prices: Figure 5: Emcore Sum of the Parts Valuation EMKR: Sum of the part valuation Business Units Sales CY09E EPS CY09E CY09E P/Sales Valuation Segment $'000 $ $'000 Share Price Fiber Optics 204, , Sattelite PV 67, , CPV 216, , , ,423, Total equity value 1,423,822.0 Shares outstanding (000) 71,000.0 CY09 Current P/E CY09 Current P/S Source: Jefferies & Co estimates Current Price $5.95 We have used our CY09 sales estimates for sum of the parts valuation of Emcore as we believe by then the company would have reached a steady state of growth. We are assigning 4.5x P/S to the terrestrial CPV business as we believe EMKR CPV business will outgrow the rest of the PV industry due to the accelerating adoption of CPV. Overall EMKR PV business has P/S multiple of 4.0x v the solar industry average of 3.9x. We have assigned 1.5x P/S to the fiber optic segment v 1.4x for the industry. These assumptions lead to a blended P/S2 of 2.7x and our $20 PT. At the current market price of $5.95, EMKR is trading at P/S2 of just 0.9x, which we believe is trough valuation for this growth stock. Figure 6: Emcore Comp Table (Figures in $MM except EPS) Rating Ticker Price Price Rev. Growth EPS. Growth % P/S EV/Sales Fiber Optics Target FY07-08 FY08-09 FY07-08 FY08-09 FY07A FY08E FY09E FY07A FY08E FY09E JDS Uniphase NC JDSU NC $ % 11.2% 103.4% 35.6% 2.3x 2.0x 1.8x 1.9x 1.7x 1.5x Optium Buy OPTM $12 $ % 26.9% -35.7% 96.3% 1.5x 1.2x 0.9x 1.1x 0.8x 0.7x Opnext Buy OPXT $7 $ % 15.8% 218.2% 8.6% 1.7x 1.4x 1.2x 0.9x 0.7x 0.6x Finisar Hold FNSR $1.75 $ % 12.9% 100.0% 116.7% 1.0x 1.0x 0.8x 1.3x 1.3x 1.2x Oplink NC OPLK NC $ % 12.3% -12.0% 78.1% 2.3x 1.3x 1.2x 1.3x 0.7x 0.6x IPG Technologies Buy IPGP $22 $ % 23.0% 23.1% 32.5% 3.7x 3.0x 2.4x 3.7x 2.9x 2.4x Average 28.5% 17.0% 66.2% 61.3% 2.1x 1.6x 1.4x 1.7x 1.4x 1.2x Solar SunPower * Buy SPWR $110 $ % 48.4% 65.1% 58.7% 7.7x 4.7x 3.2x 7.9x 4.8x 3.2x Evergreen Solar* Hold ESLR $8 $ % 220.1% 14.3% x 9.2x 2.9x 12.5x 7.7x 2.4x Energy Conversion Devices* Buy ENER $35 $ % 77.5% -72.7% - 9.5x 4.4x 2.5x 8.3x 3.9x 2.2x First Solar NC FSLR NC $ % 80.8% 77.1% 104.0% 34.3x 18.2x 10.1x 33.2x 17.7x 9.8x Suntech Power * Buy STP $63 $ % 46.0% 53.8% 60.6% 4.4x 2.9x 2.0x 4.5x 3.1x 2.1x Average 64.3% 80.8% 26.2% 60.8% 12.6x 7.3x 4.1x 11.6x 6.7x 3.7x Average of Multiples 9.2x 5.5x 3.2x 8.4x 5.0x 2.9x Emcore Buy EMKR $20 $ % 70.0% x 1.4x 0.8x 2.1x 1.3x 0.8x Source: Thomson Baseline & Jefferies & Company *Stocks covered by Jefferies Clean Tech Analyst Paul Clegg John Lau, P.E., jlau@jefferies.com, (212) Page 6 of 10
7 Emcore (EMKR) Income Statements FYE: Sep (Pro Forma) Figures in $ '000 except EPS F06A Dec 06A Mar 07A Jun 07A Sep 07A F07A Dec 07A Mar 08E Jun 08E Sep 08E F08E Dec 08E Mar 09E Jun 09E Sep 09E F09E Dec 09E Total Revenue 158,373 38,487 39,660 44,540 47, ,000 46,887 55,200 71,500 93, , , , , , , ,000 % Change Y/Y 24.1% -1.1% -3.6% 6.2% 32.9% 7.3% 21.8% 39.2% 60.5% 98.3% 57.0% -33.8% 112.0% 67.8% 28.2% 75.8% 16.4% % Change Q/Q 8.8% 3.0% 12.3% 5.6% -0.3% 17.7% 29.5% 30.4% 20.6% 4.0% 2.6% -0.4% 9.6% Cost of goods sold 129,577 30,018 31,331 34,774 37, ,137 36,132 42,504 54,841 70, ,347 83,813 86,112 87,240 84, ,129 92,748 % Change Y/Y 21.4% -8.2% -3.5% 4.3% 19.2% 2.7% 20.4% 35.7% 57.7% 91.5% 53.5% 132.0% 102.6% 59.1% 19.9% 67.4% 10.7% % Change Q/Q -3.3% 4.4% 11.0% 6.4% -2.4% 17.6% 29.0% 29.2% 18.3% 2.7% 1.3% -2.6% 9.2% Gross Margins 18.2% 22.0% 21.0% 21.9% 21.3% 21.6% 22.9% 23.0% 23.3% 24.0% 23.4% 25.5% 26.4% 27.3% 28.9% 27.1% 29.2% SG&A 35,528 8,409 11,412 7,546 10,089 37,456 9,552 9,550 10,225 11,190 40,516 11,250 11,466 11,640 11,592 45,948 12,445 % of Revenue 22.4% 21.8% 28.8% 16.9% 21.5% 22.0% 20.4% 17.3% 14.3% 12.0% 15.2% 10.0% 9.8% 9.7% 9.7% 9.8% 9.5% R&D 18,325 6,611 7,453 5,469 5,459 24,992 7,248 7,452 7,651 8,486 30,836 10,125 10,530 10,800 10,755 42,210 11,790 % of Revenue 11.6% 17.2% 18.8% 12.3% 11.6% 14.7% 15.5% 13.5% 10.7% 9.1% 11.6% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% Total Op Exp 16,800 17,002 17,875 19,676 21,375 21,996 22,440 22,347 24,235 GAAP Adjustments - (6,034) (3,542) (10,182) (9,802) Operating Income* (25,057) (12,585) (14,078) (13,431) (15,349) (25,585) (6,045) (4,306) (1,216) 2,704 (8,862) 7,313 8,892 10,320 12,189 38,714 14,017 % of Revenue -15.8% -32.7% -35.5% -30.2% -32.6% -15.1% -12.9% -7.8% -1.7% 2.9% -3.3% 6.5% 7.6% 8.6% 10.2% 8.3% 10.7% Interest Income/(Expense) (92) (531) (632) (865) (778) (100) (778) Other Gain(Loss) (209) - (73) Pretax Income* (24,056) (12,195) (14,354) (14,511) (16,190) (57,250) (6,896) (4,406) (1,166) 2,754 (9,713) 7,373 8,952 10,380 12,249 38,954 14,087 % of Revenue -15.2% -31.7% -36.2% -32.6% -34.4% -33.7% -14.7% -8.0% -1.6% 3.0% -3.6% 6.6% 7.7% 8.7% 10.3% 8.3% 10.8% Income Taxes Effective Tax Rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Net Income* (22,205) (12,195) (14,354) (14,511) (16,190) (57,250) (6,896) (4,406) (1,166) 2,754 (9,713) 7,373 8,952 10,380 12,249 38,954 14,087 % of Revenue -14.0% -31.7% -36.2% -32.6% -34.4% -33.7% -14.7% -8.0% -1.6% 3.0% -3.6% 6.6% 7.7% 8.7% 10.3% 8.3% 10.8% Shares Outstanding - Basic 49,482 50,869 50,945 51,043 51,081 50,985 52,232 60,000 63,000 63,200 59,608 63,400 63,600 63,800 64,000 63,700 64,200 Shares Outstanding - Diluted 50,002 50,869 50,945 51,043 51,081 50,985 52,232 60,000 70,000 70,200 63,108 70,400 70,600 70,800 71,000 70,700 71,200 DILUTED EPS (GAAP) ($0.52) ($0.24) ($0.28) ($0.28) ($0.32) ($1.12) ($0.27) ($0.07) ($0.02) $0.04 ($0.32) $0.10 $0.13 $0.15 $0.17 $0.55 $0.20 % Change Y/Y 2.0% % % % -70.5% % -14.2% 73.9% 94.1% 112.4% 71.1% 138.3% 272.7% 980.5% 339.7% 269.7% 88.9% % Change Q/Q -28.9% -17.5% -0.9% -11.5% 13.6% 73.2% 77.3% 335.6% 166.9% 21.1% 15.6% 17.7% 14.7% DILUTED EPS PRO FORMA ($0.36) ($0.13) ($0.18) ($0.08) ($0.13) ($0.52) ($0.13) ($0.05) $0.01 $0.06 ($0.11) $0.13 $0.15 $0.17 $0.20 $0.64 $0.22 % Change Y/Y 6.1% % % % -75.8% % 44.9% 73.9% 94.1% 112.4% 86.3% 179.3% 272.7% 980.5% 339.7% 458.0% 88.9% % Change Q/Q -33.0% -17.5% -0.9% -11.5% 58.3% 44.4% 77.3% 335.6% 166.9% 21.1% 15.6% 17.7% 14.7% John Lau (212) Source : Jefferies Company Estimates John Lau, P.E., jlau@jefferies.com, (212) Page 7 of 10
8 ANALYST CERTIFICATIONS I, John Lau, P.E., certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report. Important Disclosures As is the case with all Jefferies employees, the analyst(s) responsible for the coverage of the financial instruments discussed in this report receive compensation based in part on the overall performance of the firm, including investment banking income. We seek to update our research as appropriate, but various regulations may prevent us from doing so. Aside from certain industry reports published on a periodic basis, the large majority of reports are published at irregular intervals as appropriate in the analyst's judgement. In February 2008, Jefferies acted as Lead Placement Agent in a private placement of common stock and warrants for Emcore Corp. Concluding in October 2006, Jefferies acted as co-manager in the initial public offering of common stock for Optium Corp. In February 2007 Jefferies acted as co-manager in the initial public offering of common stock for Opnext, Inc. In December 2006, Jefferies acted as co-manager in the initial public offering of common stock for IPG Photonics. A member of David Paek's family owns shares of Energy Conversion Devices common stock. Within the past twelve months, Jefferies and/or its affiliates received non-investment banking, securities related compensation for client services it provided to EMCORE Corporation. Jefferies makes a market in EMCORE Corporation. For Important Disclosure information on companies recommended in this report, please visit our website at or call (NASDAQ:EMKR) Meanings of Jefferies & Company, Inc, Ratings Buy - Describes stocks that we expect to provide a total return (price appreciation plus yield) of 15% or more within a 12-month period. Hold - Describes stocks that we expect to provide a total return (price appreciation plus yield) of plus or minus 15% within a 12-month period. Underperform - Describes stocks that we expect to provide a total negative return (price appreciation plus yield) of 15% or more within a 12-month period. Our focus on mid-capitalization and growth companies implies that many of the companies we cover are typically more volatile than the overall stock market, which can be amplified for companies with an average stock price consistently below $10. For companies in this category only, the expected total return (price appreciation plus yield) for Buy rated stocks is 20% or more within a 12-month period. For Hold rated stocks with an average stock price consistently below $10, the expected total return (price appreciation plus yield) is plus or minus 20% within a 12-month period. For Underperform rated stocks with an average stock price consistently below $10, the expected total return (price appreciation plus yield) is minus 20% within a 12-month period. NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/or Jefferies & Company, Inc. policies. CS - Coverage Suspended. Jefferies & Company, Inc. has suspended coverage of this company. NC - Not covered. Jefferies & Company, Inc. does not cover this company. Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations. Monitor - Describes stocks whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided. John Lau, P.E., jlau@jefferies.com, (212) Page 8 of 10
9 Valuation Methodology Jefferies' methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months. Risk which may impede the achievement of our Price Target This report was prepared for general circulation and does not provide investment recommendations specific to individual investors. As such, the financial instruments discussed in this report may not be suitable for all investors and investors must make their own investment decisions based upon their specific investment objectives and financial situation utilizing their own financial advisors as they deem necessary. Past performance of the financial instruments recommended in this report should not be taken as an indication or guarantee of future results. The price, value of, and income from, any of the financial instruments mentioned in this report can rise as well as fall and may be affected by changes in economic, financial and political factors. If a financial instrument is denominated in a currency other than the investor's home currency, a change in exchange rates may adversely affect the price of, value of, or income derived from the financial instrument described in this report. In addition, investors in securities such as ADRs, whose values are affected by the currency of the underlying security, effectively assume currency risk. Rating and Price Target History for: EMCORE Corporation (EMKR) as of /18/05 B:$6.5 08/03/05 B:$7 11/18/05 B:$9 02/03/06 B:$12 05/05/06 B:$16 01/08/07 B:$10 09/17/07 B:$11 10/15/07 B:$13 12/14/07 B:$18 02/27/08 B:$ Q1 Q2 Q3 Q1 Q2 Q3 Q1 Q2 Q Created by BlueMatrix Distribution of Ratings IB Serv./Past 12 Mos. Rating Count Percent Count Percent BUY [BUY/ SB] HOLD [HOLD] SELL [SU/ UNPF] OTHER DISCLOSURES This material has been prepared by Jefferies & Company, Inc. a U.S.-registered broker-dealer, employing appropriate expertise, and in the belief that it is fair and not misleading. The information upon which this material is based was obtained from sources believed to be reliable, but has not been independently verified, therefore, we do not guarantee its accuracy. Additional and supporting information is available upon request. This is not an offer or solicitation of an offer to buy or sell any security or investment. Any opinion or estimates constitute our best judgment as of this date, and are subject to change without notice. Jefferies & Company, Inc. and Jefferies International Limited and their John Lau, P.E., jlau@jefferies.com, (212) Page 9 of 10
10 affiliates and their respective directors, officers and employees may buy or sell securities mentioned herein as agent or principal for their own account. Additional information for UK and Canadian investors This material is approved for distribution in the United Kingdom by Jefferies International Limited which is authorized and regulated by the Financial Services Authority ("FSA"). While we believe this information and materials upon which this information was based are accurate, except for any obligations under the rules of the FSA, we do not guarantee its accuracy. This material is intended for use only by persons who have professional experience in matters relating to investments falling within Articles 19(5) and 49(2)(a) to (d) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or to persons to whom it can be otherwise lawfully distributed. For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein are available to other persons or to anyone in Canada who is not a "Designated Institution" as defined by the Securities Act (Ontario). This material does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this report is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments. Jefferies & Company, Inc. research reports are disseminated and available primarily electronically, and, in some cases, in printed form. Electronic research is simultaneously available to all clients. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Jefferies & Company, Inc. Jefferies International Limited has adopted a conflicts management policy in connection with the preparation and publication of research, the details of which are available upon request in writing to: The Compliance Officer, Jefferies International Limited, Vintners Place, 68 Upper Thames Street, London EC4V 3BJ; telephone +44 (0) ; facsimile +44 (0) Jefferies & Company, Inc, (NASDAQ:EMKR) John Lau, P.E., jlau@jefferies.com, (212) Page 10 of 10
Tullett Prebon (LSE: TLPR LN)
December 1, 2008 Financial Services Market Structure & Trading United Kingdom Company Update Rating: Price: Price Target: Bloomberg: BUY 150p 260p LSE: TLPR LN Market Data 52-Week Range: 540p-125p Total
More informationConsumer. Nevada Numbers - Average Nevada Income Statements Back To 1991
January 30, 2009 Consumer Casinos & Gaming Consumer Nevada Numbers - Average Nevada Income Statements Back To 1991 Investment Summary The enclosed note gives readers a financial snapshot of the typical
More informationMicron Tech. (MU) EQUITY RESEARCH AMERICAS. Moore Stress: Expect DRAM Prices to Continue to Increase. BUY Price target $10.00 Price $9.
USA Technology Semiconductors Micron Tech. (MU) Moore Stress: Expect DRAM Prices to Continue to Increase Key Takeaway DRAM spot prices have spiked up 106% and contract prices increased by 30% from their
More informationPrecision Equipment Obstacles for EUVL
INDUSTRY NOTE Japan Industrials Obstacles for EUVL Key Takeaway It seems that developing the mirror is one of the major obstacles in realizing EUVL lithography. We also summarize the other obstacles (both
More informationHealth Care Facilities
Page 1 of 5 INDUSTRY NOTE USA Healthcare Health Care Facilities July 21, 2014 Health Care Facilities Hospital Survey: Inpatient Volumes Were Positive; Expect More Doc Outsourcing Key Takeaway We conducted
More informationBiotechnology BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff
INDUSTRY NOTE USA Healthcare BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff Key Takeaway This afternoon the Form 10 for BIIB s proposed hemophilia spinoff Bioverativ was issued,
More informationFufeng Group Limited (546 HK) Second Price Increase in Two Months
COMPANY NOTE China Industrials Chemicals Fufeng Group Limited (546 HK) Second Price Increase in Two Months Key Takeaway Fufeng has adjusted its MSG prices again, the second time since late April. Excluding
More informationLattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings
USA Technology Semiconductors Lattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings Key Takeaway After hosting investor meetings with CFO Joe Bedewi and VP Ops. Doug
More informationPublic Service Ent. (PEG) Another Bad Bonus
COMPANY NOTE USA Energy Electric Utilities Public Service Ent. (PEG) Another Bad Bonus Key Takeaway PEG hosted its investor conference and affirmed 2016 ongoing EPS guidance of $2.80-$3.00 and as a result
More informationAmerican Tower (AMT) EQUITY RESEARCH AMERICAS. Strong Execution Continues. BUY Price target $ Price $90.01 COMPANY NOTE.
COMPANY NOTE USA Telecommunications Telecom Services American Tower (AMT) Strong Execution Continues Key Takeaway AMT beat on all key financial metrics, with acquisitions and strong organic growth expected
More informationFY3/17 JEF forecast. FY3/17 company forecast. Implied progression
INDUSTRY NOTE Japan Financials Financials Today at the Races Key Takeaway Today's runners: Nikkei previewed Q1 FY3/17 banks earnings; Janus reported 2Q16 results slight operating miss with positive flows;
More informationVerizon Communications (VZ) ARPA Headwinds Likely to Persist
COMPANY NOTE USA Telecommunications Telecom Services Verizon Communications (VZ) ARPA Headwinds Likely to Persist Key Takeaway Similar to 3Q, better profitability in both Wireless and Wireline drove a
More informationKinross Gold Corp. (KGC)
COMPANY NOTE USA Natural Resources Metals & Mining Kinross Gold Corp. (KGC) Good Operational Performance, Capex Lowered Key Takeaway Kinross reported adjusted 3Q EPS of $0.10, ahead of our and street s
More informationComputer Services & IT Consulting JPM Card Volume Growth Accelerates
INDUSTRY NOTE USA Technology JPM Card Volume Growth Accelerates Key Takeaway Earlier, JPM (largest V/MA credit card issuer) reported 2Q16 results. US credit card volume growth accelerated 30 bps to 8.2%
More informationAmerican Electric Power (AEP)
COMPANY NOTE USA Energy Electric Utilities American Electric Power (AEP) Strong 3Q15 and Increased 2015 Guidance Key Takeaway AEP reported 3Q15 EPS of $1.06, which beat Street expectations of $1.00 and
More informationTCL Communication (2618 HK)
COMPANY NOTE HKG Technology Comm. Equipment TCL Communication (2618 HK) Look Forward to Smartphone Growth Key Takeaway TCL Comm reported Q1 earnings materially below our/consensus expectations due to pricing
More informationStryker Corp. (SYK) EQUITY RESEARCH AMERICAS. Recon Strong in 4Q; Stability Expected for HOLD Price target $ Price $96.
COMPANY NOTE USA Healthcare Medical Supplies & Devices Stryker Corp. (SYK) Recon Strong in 4Q; Stability Expected for 2016 Key Takeaway SYK 4Q results showed a surge in recon where a good domestic volumes,
More informationHEG (HEG IN) EQUITY RESEARCH INDIA. Strong Quarter; Raising PT. BUY Price target INR5, (from INR4,400.00) Price INR4,343.
COMPANY NOTE India Natural Resources Materials (Steel) HEG (HEG IN) Strong Quarter; Raising PT Key Takeaway HEG reported strong quarter driven by higher realisation of US$14,333/t (vs US $12,500/t JEFe).
More informationDarden Restaurants, Inc.
Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because
More informationALPHA SELECT LIST CAS Medical Systems, Inc.
A Matt G. Hewitt Senior Research Analyst 612-334-6314 matthew.hewitt@craig-hallum.com Lucas Baranowski Research Analyst 612-334-8224 lucas.baranowski@craig-hallum.com Charlie Eidson, CPA Research Analyst
More informationSanDisk Corporation (SNDK) Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59
COMPANY NOTE USA Technology Semiconductors SanDisk Corporation () Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59 Key Takeaway We continue to believe Moore Stress is driving industry
More informationCEVA Inc. CEVA - $ NASDAQ Buy
Suji Desilva, CFA, (415) 306-5120 sdesilva@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH August 07, 2018 Semiconductors & IT Hardware CEVA Inc. CEVA - $32.55 - NASDAQ
More informationPARKERVISION, INC. Rating: STRONG BUY Target: $27. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits
EGE INSTITUTIONAL RESEARCH REPORT RESEARCH UPDATE DECEMBER 24, 2007 PARKERVISION, INC. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits PRKR Signs First Mobile Handset Deal; Upgrading To STRONG
More informationAmerica's Car-Mart (CRMT)
COMPANY NOTE Target Estimate Change USA Financials Consumer Finance February 20, 2014 America's Car-Mart (CRMT) CRMT 3Q14: Competitive Intensity Leads to Higher Credit Costs Key Takeaway CRMT missed consensus
More informationBCD Semiconductor (BCDS)
COMPANY NOTE USA Technology Semiconductors BCD Semiconductor (BCDS) Moore Stress Beneficiary Taking Share - Buy Key Takeaway Q3 EPS beat highlights another quarter of consistent execution and share gains
More informationMajor Bulk Commodities: Trends and Outlook
Major Bulk Commodities: Trends and Outlook June 19, 2013 Christopher LaFemina European Metals and Mining Equity Research US: 212 336 7304 UK: +44 (0)207 029 8131 clafemina@jefferies.com Jefferies LLC Seaborne
More informationPARKERVISION, INC. Rating: BUY Target: $27. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits
EGE INSTITUTIONAL RESEARCH REPORT RESEARCH UPDATE MAY 3, 2007 PARKERVISION, INC. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits PRKR Announced A $25 Million Licensing Agreement With ITT Corp
More informationAllscripts Healthcare Solutions, Inc.
HEALTHCARE: Healthcare Technology Company Update / Estimates Change Allscripts Healthcare Solutions, Inc. MDRX: Continuing the String of Bookings We reiterate our SW rating on Allscripts (MDRX) due to
More informationApple Inc. EQUITY RESEARCH ESTIMATE CHANGE. Buy. AAPL - NASDAQ November 3, Enterprise & Consumer Technology
EQUITY RESEARCH ESTIMATE CHANGE Enterprise & Consumer Technology AAPL - NASDAQ November 3, 2017 Closing Price 11/2/2017 $168.11 Rating: Buy 12-Month Target Price: $193.00 52-Week Range: $104.08 - $169.94
More informationIndustry Overview February 16, 2010
Industry Overview February 16, 2010 Enterprise Software Brendan Barnicle 503.727.0624 bbarnicle@pacific-crest.com Matthew Coss 503.727.0622 mcoss@pacific-crest.com With Expectations Reset, Time to Add
More informationO'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit
EQUITY RESEARCH QUARTERLY UPDATE July 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $300.00 ORLY - NASDAQ $277.51 3-5 Yr. EPS Gr. Rate 18% 52-Wk Range $284.66-$225.12 Shares Outstanding 99.4M
More informationChina Renewable Energy Investment Ltd (987_HK)
Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9
More informationAlvarion Ltd. Rating: Buy
TECHNOLOGY Kevin Dede, CFA 212-218-3714 kdede@morganjoseph.com Company Update June 11, 2008 Key Metrics ALVR - NASDAQ $7.95 Pricing Date 06/11/2008 Price Target $11.00 52-Week Range $15.21-$5.20 Shares
More informationStrides Arcolab (STR IN)
COMPANY NOTE India Healthcare Pharmaceuticals Strides Arcolab () 1Q18: Weak quarter; Expect recovery ahead Key Takeaway STR reported weak 1Q18 as approval delays, mix and operating leverage drove 700bps
More informationFinisar Announces Record Annual Revenues for Fiscal 2011
June 15, 2011 Finisar Announces Record Annual Revenues for Fiscal 2011 Record Annual Revenues of $948.8 Million, 50.6% Y-Y Growth Annual Non-GAAP Operating Margin of 15.6% Record Annual Non-GAAP Earnings
More informationFLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook
ELANIX BIOTECHNOLOGIES AG Biotechnology 8 August 2018 09:54 BST FLASH NOTE Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook OUTPERFORM Price target 6.40 Price 2.72 KEY
More informationAutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving
Consumer: Automotive Retail AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Maintaining SW: 1) auto retail industry growth outlook remains
More informationCentral European Media Enterprises Rating: Buy
SATELLITE, CABLE & BROADCASTING David B. Kestenbaum 212-218-3851 dkestenbaum@morganjoseph.com Company Update July 29, 2008 Key Metrics CETV - NASDAQ $82.82 Pricing Date 07/28/2008 Price Target $150.00
More informationAutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016
EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M
More informationE-FIT trial results indicate no clinical improvement
NEXSTIM OYJ Medical Technology 3 September 2018 11:44 BST FLASH NOTE Nexstim OYJ (NXTMH-FI) E-FIT trial results indicate no clinical improvement OUTPERFORM Price target 1.23 Price 0.23 KEY TAKEAWAY Today,
More informationKBL Mining Limited. Exciting Times Ahead. APP Securities Company Research 4 August 2015 KBL A$0.03 TARGET PRICE A$0.10 BUY
APP Securities Company Research 4 August 2015 KBL Mining Limited KBL A$0.03 TARGET PRICE A$0.10 BUY KBL Mining Ltd operates the Mineral Hill copper lead gold mine in NSW, Australia, and holds a 75% interests
More informationAveXis (AVXS) EQUITY RESEARCH AMERICAS. Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial. BUY Price target $50.00 Price $41.
COMPANY NOTE USA Healthcare Biotechnology AveXis (AVXS) Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial Key Takeaway Since there are investor questions surrounding AVXS' ability to
More informationResearch in Motion (RIMM)
COMPANY NOTE USA Technology Telecom Equipment/Wireless Research in Motion (RIMM) Limited Patent Value; Cut Target to Salvage Value of $21 as We Wait for QNX Key Takeaway In consultation with industry experts,
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Emergent BioSolutions (EBS - $34.89) Another Acquisition in EBS s Wheelhouse, 2020 Topline $1B Goal in Sight Yesterday
More informationSemiconductors Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming
INDUSTRY NOTE USA Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming Key Takeaway Data from 37 semiconductor earnings reports shows that at the median, semis lowered 4Q revenue expectations
More informationAnalyst's Notes. Argus Recommendations
Report created Nov 14, 2017 Page 1 OF 5 First Solar designs, develops, manufactures and markets a line of thin-film semiconductor photovoltaic (PV) cells and modules that convert sunlight into electricity.
More information22nd Century Group, Inc. (XXII - $ Buy) Q3 Better than Expected
Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $1.33 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Analyst, +1-646-465-9034 jmcilree@chardancm.com Sales
More informationSocket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC
October 27, 2017 Company Sponsored Research Morning Meeting Note Earnings Release Socket Mobile, Inc. (SCKT) Equity Research Maintain $6 Price Target; Robust Demand From Application Developer, Despite
More informationThe Medicines Company Model Update; Busy Catalyst Calendar Ahead
EQUITY RESEARCH QUARTERLY UPDATE March 23, 2016 Stock Rating: PERFORM 12-18 mo. Price Target NA MDCO - NASDAQ $31.48 3-5 Yr. EPS Gr. Rate NA 52-Wk Range $43.79-$25.27 Shares Outstanding 68.9M Float 67.1M
More informationSTEC Inc. Bringing Out the Big Gun--2H Contract Ups Visibility, Ests, PT, Everything
EQUITY RESEARCH COMPANY UPDATE July 16, 2009 Stock Rating: OUTPERFORM 12-18 mo. Price Target $45.00 STEC - OTC $27.59 3-5 Yr. EPS Gr. Rate 105% 52-Wk Range $28.37-$3.42 Shares Outstanding 48.4M Float 31.7M
More informationAmerican Tower Corp. AMT 3Q16 Results: Solid Quarter with a Beat and Raise on EBITDA
EQUITY RESEARCH COMPANY UPDATE October 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $130.00 AMT - NYSE $115.67 3-5 Yr. EPS Gr. Rate 20% 52-Wk Range $118.26-$83.07 Shares Outstanding 430.0M
More informationWe Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation
July 13, 2018 Company Sponsored Research Morning Meeting Note Raise Price Target Sify Technologies Limited Sponsored ADR (SIFY) Equity Research We Raise Our Price Target To $4 (From $3); Think Strong Outlook
More informationCalAmp Corp. CAMP - $ NASDAQ Buy
Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH June 28, 2018 Technology: Communications, Wireless & IoT CalAmp Corp. CAMP
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.07) Impressive Ex-US Sales Help ALIM Exceed Topline Expectations. ALIM recently announced
More informationYamaha Motor (7272 JP)
COMPANY NOTE JPN Industrials Autos & Auto Parts Yamaha Motor (7272 JP) Initiate at Hold: Concern over Declining Competitiveness in Emerging Countries Key Takeaway Investment sentiment for Yamaha would
More informationSlater & Gordon Limited
BBY Company Research 29 November 2013 Slater & Gordon Limited SGH A$4.39 TARGET PRICE A$5.00 BUY 0.5X Slater & Gordon Limited (SGH) is a national law firm. The Firm's areas of practice include commercial,
More informationSimmtech (222800) Focus on 2H earnings WHAT S THE STORY?
Company Update Simmtech (222800) Focus on 2H earnings Simmtech yesterday reported disappointing 4Q results, which compels us to cut our 2018 operating profit forecast by 10% to KRW52.9b and 12-month target
More informationRCN Corporation Rating: Hold
SATELLITE, CABLE & BROADCASTING David B. Kestenbaum 212-218-3851 dkestenbaum@morganjoseph.com James Leahy 212-218-3784 jleahy@morganjoseph.com Company Update / Estimates Change March 15, 2007 Key Metrics
More informationEquity Research. Verizon Communications Inc. VZ: Resuming Equity Research Coverage At Outperform. Outperform. October 14, 2016
October 14, 2016 Equity Research Verizon Communications Inc. VZ: Resuming Equity Research Coverage At Outperform On August 1, 2016, we suspended equity research coverage on Verizon Communications Inc.
More informationJefferies Group Another Hack Attack
EQUITY RESEARCH COMPANY UPDATE November 23, 2011 Stock Rating: PERFORM 12-18 mo. Price Target NA JEF - NYSE $10.06 3- Yr. EPS Gr. Rate NA 2-Wk Range $27.12-$9.0 Shares Outstanding 199.7M Float 148.3M Market
More informationJefferies & Co., Inc. Electric Utilities Group
Jefferies & Co., Inc. Electric Utilities Group Paul Fremont (212) 284-2466 pfremont@jefferies.com Anthony Crowdell (212) 284-2563 acrowdell@jefferies.com January 11, 2012 1 Fixed Cost ($/kw) for Different
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.80) Iluvien sales continue their slow & steady growth ALIM reported 1Q16 roughly in-line
More information22nd Century Group, Inc. (XXII - $ Buy)
Company Update Agriculture Technology (XXII - $0.97 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Analyst, 646-465-9034 jmcilree@chardancm.com Sales and trading 7 a.m. to 7 p.m. ET, (646)
More informationEquity Research. Cummins Inc. CMI: Headwinds Continue Adjusting Estimates & Maintain Market Perform. Market Perform.
August 2, 2016 Equity Research CMI: Headwinds Continue Adjusting Estimates & Maintain Market Perform Summary: CMI continued to encounter difficult end market conditions that deteriorated through Q2 16
More informationEquity Research. American Tower REIT, Inc. AMT: Solid Q Results--Shows Strength Of Geo-Diverse Model. Outperform.
October 28, 2016 Equity Research American Tower REIT, Inc. AMT: Solid Q3 2016 Results--Shows Strength Of Geo-Diverse Model AMT reported solid Q3 2016 results that beat our estimates across the board. The
More informationSingyes Solar (00750.HK/750 HK)
Singyes Solar (00750.HK/750 HK) Margin decline not a concern for earnings growth HK$12.64 Outperform Maintained 1 Huei-chen Flannery 2 852.2878.4270 3 hueichen.flannery@kgi.com Company update Estimate
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 7, 2018 Alimera Sciences (ALIM - $1.09) Quarter Mostly in-line, 2019 could Benefit from Repeat Usage ALIM
More informationKBRO KAUFMAN BROS. MORNING EXCHANGE. July 10, In Today's Morning Exchange:
In Today's Morning Exchange: Initiation of Coverage American Superconductor Corp. Earnings Previews Google Company/Industry Comments IT Services & Software CHINA WIND TURBINE MARKET AT 10GW NOW THOUGHTS
More informationAAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC
December 16, 2016 Morning Meeting Note Raise Price Target AAON, Inc. (AAON) Equity Research Raise Target To $34 (From $28) On Anticipation Of A Lower Tax Rate; Continue To Forecast Strong Growth In 2017-2018;
More informationStryker Corp. Post-4Q15 Thoughts
EQUITY RESEARCH QUARTERLY UPDATE January 27, 2016 Stock Rating: PERFORM 12-18 mo. Price Target $104.00 SYK - NYSE $96.02 3-5 Yr. EPS Gr. Rate 9% 52-Wk Range $105.34-$86.68 Shares Outstanding 378.4M Float
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report August 10, 2018 Emergent BioSolutions (EBS - $56.46) EBS Makes Significant Strides Towards 2020 Goals with PaxVax Acquisition,
More informationDetour Gold Corporation (DGC-T)
Detour Gold Corporation (DGC-T) Q2 Results Advancing Towards Full Production August 6, 2014 Michael Curran, CFA (416) 507-3950 mcurran@beaconsecurities.ca Detour Gold s focus is the continuing ramp up
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive April 3, 2019 Lisa Thompson 312-265-9517 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 O2Micro International Ltd
More informationPure Technologies Ltd.
12 July 2016 Special Situations Pure Technologies Ltd. Introducing Pure as Top Pick for H216 PUR-TSX: $5.95 Buy $7.25 Target We are pleased to introduce Pure Technologies ( PUR, Pure, or the Company )
More informationKIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold
Latin American Equity Research Mexico City, November 20, 2006 KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold Joaquín Ley* Mexico: Santander Banco Santander S.A. 5255) 5269-1921 jley@santander.com.mx
More informationResults for Q1 Fiscal 2018
Results for Q1 Fiscal 2018 Earnings Announcement: July 27, 2017 (Quarter Ending June 30, 2017) Risks and Non-GAAP Disclosures This presentation contains forward-looking statements, which are based on current
More informationTrailing PE Forward PE Buy 3 Analysts. 1-Year Return: -35.3% 5-Year Return: 339.3%
TON CONTROL INC (-T) Last Close 1.34 (CAD) Avg Daily Vol 169,152 52-Week High 2.60 Trailing PE 16.8 Annual Div -- ROE 21.7% LTG Forecast -- 1-Mo 55.8% 2019 January 25 TORONTO Exchange Market Cap 147M 52-Week
More information7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10
FIRST BERLIN Equity Research 12 7C Solarparken AG 7 RATING Germany / Cleantech Preliminary 2014 Primary Exchange: Frankfurt PRICE TARGET 2.10 Bloomberg: HRPK GF figures Return Potential 13.9% ISIN: DE000A11QW68
More informationFUV: $4.5 million capital raise and Florida Keys franchise agreement. Company Update December 28, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology Arcimoto, Inc. (FUV - $2.01 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m.
More informationADVA Optical Networking FY12 results
ADVA Optical Networking FY12 results Cautious start to the year ADVA reported Q4 revenues in line with guidance and better than expected profitability. However, guidance for Q113 was below our expectations
More informationFQ1 Brings Another Strong Quarter Of Revenue Growth
Canopy Growth Corp. (CGC-T: C$3.79) August 30, 2016 BUY Dundee Target: C$4.75 Daniel Pearlstein / (647) 253-1160 dpearlstein@dundeecapitalmarkets.com FQ1 Brings Another Strong Quarter Of Revenue Growth
More informationGolden Entertainment, Inc. Global Gaming Operators GDEN NASDAQ $28.72 Company Update
16 March 2018 North American Research Rating: Buy Price Target: $40.00 Price $28.72 52wk Range $11.70 - $26.33 Shares Outstanding (MM) 26.4 Market Capitalization (MM) $757.4 Enterprise Value (MM) $1,657.4
More informationBTO: Q2/15 Earnings Preview
B2Gold Corp. (BTO-T: C$1.69), (BTG-N: US$1.31) August 13, 2015 BUY, High Risk Dundee target: C$2.75 BTO: Q2/15 Earnings Preview Joseph Fazzini, CPA, CA, CFA / (647) 428-8248 jfazzini@dundeecapitalmarkets.com
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report March 2, 2018 Durect Corporation (DRRX - $1.32) DUR-928 Front and Center Stage in 2018 DRRX reported their 4Q17 last
More informationMillicom International Cellular Rating: Buy
SATELLITE, CABLE & BROADCASTING David B. Kestenbaum 212-218-3851 dkestenbaum@morganjoseph.com Heather Hou 212-218-3713 hhou@morganjoseph.com Company Update October 7, 2008 Key Metrics MICC - NASDAQ $58.45
More informationResults for Q2 Fiscal 2018
Results for Q2 Fiscal 2018 Earnings Announcement: October 26, 2017 (Quarter Ending September 29, 2017) Risks and Non-GAAP Disclosures This presentation contains forward-looking statements, which are based
More informationEquity Research. Rockwell Collins, Inc. COL: Reduce FQ1 For Higher Restructuring; Savings To Offset. Outperform. November 16, 2015
November 16, 2015 Equity Research Rockwell Collins, Inc. COL: Reduce FQ1 For Higher Restructuring; Savings To Offset Summary. Rockwell Collins announced after the close on November 13 that its expected
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive January 23, 2019 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 TowerJazz (TSEM-NASDAQ)
More informationSPECULATIVE BUY Target: C$1.40. Event. Impact. Action
Daily Letter 1 Intrinsyc Software International Inc. ICS : TSX : C$0.49 SPECULATIVE BUY Target: C$1.40 Peter Misek, CA, CPA, CFA 1.416.869.7920 peter.misek@canaccordadams.com Dushan Batrovic, MBA 1.416.869.7399
More informationIndustry: CABLE TV August 7, 2013 Recommendation: BUY. Company Overview
Price Target $74.09 Price (08/07/2013) $61.11 52-WK ($) 47.71-67.85 Market Cap ($M) $34,000 Outstanding Shares 556 Insider % 7.0 Revenue $30,750 Valuation TEV ($M) $50,590 EBITDA ($M) $7,480 EV/EBITDA
More informationZoe's Kitchen, Inc. ZOES NYSE Buy Restaurants
One Year Price Chart March 11, 2015 Zoe's Kitchen, Inc. ZOES NYSE Buy Restaurants Company Update Posts High Quality '+$0.01 Better' 4Q14 OpEPS; Issues 'In Line to Better' 2015 Guidance We reiterate our
More informationResearch Report- Update
The Standard of Excellence in the Microcap Market Member: NASD, SIPC Buy Research Report- Update Robert C. Schroeder UFP Technologies, Inc. May 15, 2000 Ticker: UFPT--$2.56 (NASDAQ) FY1997 FY1998 FY1999A
More informationAAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC
December 13, 2018 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research In Our View, AAON s Outlook For 2019 Is Positive Based On Backlog, Order Trend And Price/Cost; However, We Are Cautious
More informationEnbridge Energy Partners, L.P.
Equity Research Earnings Update April 30, 2007 Stock Rating: Sector Performer Sector Weighting: Market Weight 12-18 mo. Price Target $60.00 EEP-NYSE (4/27/07) $61.19 Key Indices: None 3-5-Yr. EPS Gr. Rate
More informationVerizon Communications Inc.
April 22, 2016 Verizon Communications Inc. VZ * - NYSE Rating: Neutral Price: (4/21/16) $50.03 Price Targets: 12-18 month: $53 5-year: $57 Industry: Telecommunications James G. Moorman, CFA 212.240.9863
More informationFLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target SEK43.00 Price SEK Vicore Pharma Holding AB (VICO-SE)
VICORE PHARMA HOLDING AB Biotechnology 3 July 2018 12:10 BST FLASH NOTE Vicore Pharma Holding AB (VICO-SE) Acquisition of INIM brings HealthCap on board OUTPERFORM Price target SEK43.00 Price SEK11.50
More informationSierra Wireless, Inc. SWIR - $ NASDAQ Buy
Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH August 03, 2018 Technology: Communications, Wireless & IoT Sierra Wireless,
More informationSUNSI ENERGIES, INC. Best Play on the Solar Market
SUNSI ENERGIES, INC. Best Play on the Solar Market Rob Goldman May 6, 2011 rob@goldmanresearch.com SUNSI ENERGIES, INC. (OTC:QB - SSIE - $3.10) Price Target: $6.00 Rating: Speculative Buy COMPANY SNAPSHOT
More informationComcast EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Comcast 2Q16 Follow-Up: Raising Price Target to $74, 8x 2017E EBITDA.
EQUITY RESEARCH QUARTERLY UPDATE July 29, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $74.00 CMCSA - NASDAQ $67.86 3-5 Yr. EPS Gr. Rate 17% 52-Wk Range $68.36-$50.01 Shares Outstanding 2,446.0M
More informationRCN Corporation Rating: Buy
SATELLITE, CABLE & BROADCASTING David B. Kestenbaum 212-218-3851 dkestenbaum@morganjoseph.com James Leahy 212-218-3784 jleahy@morganjoseph.com Company Update September 7, 2007 Key Metrics RCNI - NASDAQ
More information